Verapamil Hydrochloride Injection shortage
To Be Discontinued 1 presentations · 1 manufacturers · first FDA posting 2025-11-21 · last update 2025-11-21
Manufacturers: Pfizer Inc.
Stated reasons (per FDA): Not stated
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Verapamil Hydrochloride, Injection, 2.5 mg/1 mL (NDC 0409-9633-05) | Pfizer Inc. | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted 11/21/2025 Updated 11/21/2025 Discontinued 11/21/2025 |
Get the weekly shortage roundup: a free email of FDA shortage changes (open form)